Listen to this page using ReadSpeaker
Posts tagged BEST1

Ophthotech to Boost Development of Gene Therapy for Best Disease

Audio version:

Ophthotech Corporation, a biopharmaceutical company focused on the development of therapies for orphan retinal diseases and age-related macular degeneration, has announced an evolving, commercial partnership with the University of Pennsylvania and University of Florida to develop a gene therapy for Best disease caused by BEST1 mutations.
Continue Reading…

Please follow and like us: